首页> 外国专利> Pharmaceutical dosage form with Breaking Strength of at least 500 N, which contains an active ingredient, 5 to 70 by weight of an inorganic Salt,At least 30 by weight of a polyalkylene oxide, wherein the active ingredient is embedded in a Matrix of controlled release that includes inorganic Salt and polyalkylene oxide.

Pharmaceutical dosage form with Breaking Strength of at least 500 N, which contains an active ingredient, 5 to 70 by weight of an inorganic Salt,At least 30 by weight of a polyalkylene oxide, wherein the active ingredient is embedded in a Matrix of controlled release that includes inorganic Salt and polyalkylene oxide.

机译：具有至少500 N的断裂强度的药物剂型，其中含有活性成分，5至70％重量的无机盐，至少30％重量的聚环氧烷，其中活性成分包埋在控制释放，包括无机盐和聚环氧烷。

页面导航

摘要
著录项
相似文献

摘要

Pharmaceutical dosage form with Breaking Strength of at least 500 N, which contains an active ingredient, 5 to 70% by weight of an inorganic Salt,At least 30% by weight of a polyalkylene oxide, wherein the active ingredient is embedded in a Matrix controlled release comprising polyalkylene oxide and inorganic Salt.

机译：具有至少500 N的断裂强度的药物剂型，其中含有活性成分，5至70％重量的无机盐，至少30％重量的聚环氧烷，其中活性成分包埋在基质控制的基质中释放包括聚环氧烷和无机盐。

著录项

公开/公告号CL2013000437A1

专利类型
公开/公告日2013-04-12

原文格式PDF
申请/专利权人 GRÜNENTHAL GMBH;
展开▼

申请/专利号CL20130000437
发明设计人 BARNSCHEID LUTZ;
展开▼

申请日2013-02-13
分类号A61K9/16;A61K9/20;A61K47/02;
国家 CL
入库时间 2022-08-21 16:42:06

相似文献

专利
外文文献